Eli Lilly Retained Earnings (Accumulated Deficit) 2010-2025 | LLY
Eli Lilly retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $15.100B, a 20.28% increase year-over-year.
- Eli Lilly retained earnings (accumulated deficit) for 2024 were $13.545B, a 31.35% increase from 2023.
- Eli Lilly retained earnings (accumulated deficit) for 2023 were $10.312B, a 2.69% increase from 2022.
- Eli Lilly retained earnings (accumulated deficit) for 2022 were $10.043B, a 12.1% increase from 2021.